Search HQY
HEALTHEQUITY, INC.
Nasdaq · CIK 1428336
Last close90.04
Daily change+0.67 (0.75%)
10 Years gain+137.76%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
HQY · STANDARD
SIC 7389 · Services-Business Services, NEC · Fiscal year end 0131
Fundamental
64.6Momentum
100.0Acceleration
100.0Confidence
90.0Annual Revenue14
Quarterly Revenue63
Annual CFO14
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth19.1 / 25
Quality20.7 / 25
Capital Efficiency7.2 / 20
Balance Sheet8.5 / 15
Shareholder Economics9.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 5.3706 percentage points.
Operating leverageOperating margin improved by 10.6582 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 4.9777%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM11.04%OK
Revenue CAGR 3Y15.08%OK
Gross Margin72.04%OK
Operating Margin27.34%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC10.08%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-4.98%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jan 31, 2026 | $1.31B | $913.12M | $322.46M | $457.09M | $455.13M | 69.52% | 24.55% | 34.65% | 8.9% | 87.47M |
| 2026 FY Jan 31, 2025 | $1.20B | $777.26M | $162.33M | $339.86M | $337.77M | 64.78% | 13.53% | 28.15% | 5.03% | 88.83M |
| 2026 FY Jan 31, 2024 | $999.59M | $622.64M | $117.70M | $242.83M | $241.13M | 62.29% | 11.77% | 24.12% | 3.45% | 86.96M |
| 2025 FY Jan 31, 2023 | $861.75M | $491.94M | $9.06M | $150.65M | $147.28M | 57.09% | 1.05% | 17.09% | 0.28% | 84.44M |
| 2024 FY Jan 31, 2022 | $756.56M | $424.77M | -$24.24M | $141.00M | $132.09M | 56.14% | -3.2% | 17.46% | -0.83% | 83.13M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.35B | sum latest 4 fiscal quarters Revenue | OK | 0001428336-26-000041, 0001428336-25-000036 |
| Revenue Growth TTM | 11.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001428336-26-000041, 0001428336-25-000036 |
| Revenue CAGR 3Y | 15.08% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001428336-26-000010 |
| Revenue CAGR 5Y | 12.36% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001428336-26-000010 |
| Gross Profit CAGR 3Y | 22.9% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001428336-26-000010 |
| Operating Income Growth | 82.01% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001428336-26-000041, 0001428336-25-000036 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 72.04% | Gross Profit / Revenue | OK | 0001428336-26-000041, 0001428336-25-000036 |
| Operating Margin | 27.34% | Operating Income / Revenue | OK | 0001428336-26-000041, 0001428336-25-000036 |
| ROIC | 10.08% | NOPAT / Average Invested Capital | OK | 0001428336-26-000041, 0001428336-25-000036 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001428336-26-000041 |
| Current Ratio | 2.99x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.28x | (Cash + Short-term Investments) / Total Debt | OK | 0001428336-26-000041 |
| Revenue per Diluted Share | $16.11 | Revenue / Diluted Shares | OK | 0001428336-26-000041, 0001428336-25-000036 |